Fast Market Research

New Market Study: "Ultragenyx Pharmaceutical Inc. - Product Pipeline Review - 2012"

New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research


Boston, MA -- (SBWIRE) -- 01/11/2013 -- Global Market Direct's pharmaceuticals report, "Ultragenyx Pharmaceutical Inc. - Product Pipeline Review - 2012" provides data on the Ultragenyx Pharmaceutical Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Ultragenyx Pharmaceutical Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Ultragenyx Pharmaceutical Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


- Ultragenyx Pharmaceutical Inc. - Brief Ultragenyx Pharmaceutical Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Ultragenyx Pharmaceutical Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Ultragenyx Pharmaceutical Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Ultragenyx Pharmaceutical Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get this Report

- Evaluate Ultragenyx Pharmaceutical Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Ultragenyx Pharmaceutical Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Ultragenyx Pharmaceutical Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Ultragenyx Pharmaceutical Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Ultragenyx Pharmaceutical Inc. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Taiho Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012
- Ono Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012
- Santen Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012
- Kissei Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012
- BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2012
- Chugai Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012
- Lee's Pharmaceutical Holdings Limited - Product Pipeline Review - 2012
- Simcere Pharmaceutical Group - Product Pipeline Review - 2012
- Dong-A Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012
- Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012